Imidazoline Receptors

Imidazoline binding sites were originally classified into I1 sites (labeled by clonidine) and I2 sites (labeled by idazoxan). I2 sites have been further classified into I2A (amiloride-sensitive) and I2B (amiloride-insensitive). A putative I3 has been described which enhances insulin secretion.

Targets
Literature
Receptor Data

Imidazoline Receptor Target Files

Related Targets

    Imidazoline receptors have a physiological role in the central regulation of blood pressure. Activation of I1 receptors decreases sympathetic tone via a central mechanism, which has a hypotensive effect and reduces plasma catecholamine levels. In contrast, I2-mediated monoamine oxidase inhibition has a hypertensive effect and increases plasma catecholamine levels.

    Literature for Imidazoline Receptors

    New Product Guide

    New Product Guide (Spring/Summer 2017)

    Our new product guide highlights over 130 new products added to the Tocris Bioscience range during the first half of 2017.

    • 7-TM Receptors
    • Enzymes
    • Enzyme-Linked Receptors
    • Ion Channels
    • Nuclear Receptors
    • Transporters
    • Apoptosis
    • Cell Metabolism
    • Epigenetics
    • Fluorescent Imaging
    • Signal Transduction
    • Stem Cells

    Properties of Imidazoline Receptors

    Receptor I1 I2 I3
    Location Lateral reticular nucleus, locus ceruleus, kidney, platelets, pancreas Interpeduncular and arcuate nuclei, pineal gland, liver, kidney, heart, striated muscle, MAO Pancreatic β cells
    Transduction Mechanism ↑ Diacylglycerol and arachidonic acid Unknown Unknown
    Key Selective Ligands AGN 192403 (1072)
    Clonidine (0690)
    Rilmenidine (0790)
    BU 239 (0726)
    RS 45041-190 (0889)
    2-BFI (0348)
    KU14R (1131)
    Putative Endogenous Ligands Agmatine (0842), Harmane (1132)